Cemiplimab plus chemotherapy versus chemotherapy alone in non-small cell lung cancer: a randomized, controlled, double-blind phase 3 trial

Miranda Gogishvili, Tamar Melkadze, Tamta Makharadze, Davit Giorgadze, Mikhail Dvorkin, Konstantin Penkov, Konstantin Laktionov, Gia Nemsadze, Marina Nechaeva, Irina Rozhkova, Ewa Kalinka, Christian Gessner, Brizio Moreno-Jaime, Rodolfo Passalacqua, Siyu Li, Kristina McGuire, Manika Kaul, Anne Paccaly, Ruben G. W. Quek, Bo Gao, Frank Seebach, David M. Weinreich, George D. Yancopoulos, Israel Lowy, Giuseppe Gullo, Petra Rietschel

Open source

DOI: 10.1038/s41591-022-01977-y
Published: 2022-08-25
Container: Nature Medicine
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41591-022-01977-y,
  title = {Cemiplimab plus chemotherapy versus chemotherapy alone in non-small cell lung cancer: a randomized, controlled, double-blind phase 3 trial},
  author = {Miranda Gogishvili and Tamar Melkadze and Tamta Makharadze and Davit Giorgadze and Mikhail Dvorkin and Konstantin Penkov and Konstantin Laktionov and Gia Nemsadze and Marina Nechaeva and Irina Rozhkova and Ewa Kalinka and Christian Gessner and Brizio Moreno-Jaime and Rodolfo Passalacqua and Siyu Li and Kristina McGuire and Manika Kaul and Anne Paccaly and Ruben G. W. Quek and Bo Gao and Frank Seebach and David M. Weinreich and George D. Yancopoulos and Israel Lowy and Giuseppe Gullo and Petra Rietschel},
  year = {2022},
  journal = {Nature Medicine},
  doi = {10.1038/s41591-022-01977-y},
  url = {https://doi.org/10.1038/s41591-022-01977-y}
}

RIS

TY  - JOUR
TI  - Cemiplimab plus chemotherapy versus chemotherapy alone in non-small cell lung cancer: a randomized, controlled, double-blind phase 3 trial
AU  - Miranda Gogishvili
AU  - Tamar Melkadze
AU  - Tamta Makharadze
AU  - Davit Giorgadze
AU  - Mikhail Dvorkin
AU  - Konstantin Penkov
AU  - Konstantin Laktionov
AU  - Gia Nemsadze
AU  - Marina Nechaeva
AU  - Irina Rozhkova
AU  - Ewa Kalinka
AU  - Christian Gessner
AU  - Brizio Moreno-Jaime
AU  - Rodolfo Passalacqua
AU  - Siyu Li
AU  - Kristina McGuire
AU  - Manika Kaul
AU  - Anne Paccaly
AU  - Ruben G. W. Quek
AU  - Bo Gao
AU  - Frank Seebach
AU  - David M. Weinreich
AU  - George D. Yancopoulos
AU  - Israel Lowy
AU  - Giuseppe Gullo
AU  - Petra Rietschel
PY  - 2022
JO  - Nature Medicine
DO  - 10.1038/s41591-022-01977-y
UR  - https://doi.org/10.1038/s41591-022-01977-y
ER  -

APA

Gogishvili, M., Melkadze, T., Makharadze, T., Giorgadze, D., Dvorkin, M., Penkov, K., Laktionov, K., Nemsadze, G., Nechaeva, M., Rozhkova, I., Kalinka, E., Gessner, C., Moreno-Jaime, B., Passalacqua, R., Li, S., McGuire, K., Kaul, M., Paccaly, A., Quek, R. G. W., Gao, B., Seebach, F., Weinreich, D. M., Yancopoulos, G. D., Lowy, I., Gullo, G., & Rietschel, P. (2022). Cemiplimab plus chemotherapy versus chemotherapy alone in non-small cell lung cancer: a randomized, controlled, double-blind phase 3 trial. Nature Medicine. https://doi.org/10.1038/s41591-022-01977-y

Source records

crossref · retrieved 2026-09-27T16:48:23.697Z